Citation: Dm. Kokkinakis et al., Thresholds of O-6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide, CLIN CANC R, 7(2), 2001, pp. 421-428
Citation: Tyy. Fong et al., alpha-Difluoromethylornithine induction of apoptosis: A mechanism which reverses pre-established cell proliferation and cancer initiation in esophageal carcinogenesis in zinc-deficient rats, CANC EPID B, 10(3), 2001, pp. 191-199
Citation: Cs. Coleman et Ae. Pegg, Polyamine analogues inhibit the ubiquitination of spermidine/spermine N-1-acetyltransferase and prevent its targeting to the proteasome for degradation, BIOCHEM J, 358, 2001, pp. 137-145
Authors:
Stefanelli, C
Pignatti, C
Tantini, B
Fattori, M
Stanic, I
Mackintosh, CA
Flamigni, F
Guarnieri, C
Caldarera, CM
Pegg, AE
Citation: C. Stefanelli et al., Effect of polyamine depletion on caspase activation: a study with sperminesynthase-deficient cells, BIOCHEM J, 355, 2001, pp. 199-206
Authors:
Pegg, AE
Goodtzova, K
Loktionova, NA
Kanugula, S
Pauly, GT
Moschel, RC
Citation: Ae. Pegg et al., Inactivation of human O-6-alkylguanine-DNA alkyltransferase by modified oligodeoxyribonucleotides containing O-6-benzylguanine, J PHARM EXP, 296(3), 2001, pp. 958-965
Citation: Pm. Bauer et al., Nitric oxide inhibits ornithine decarboxylase via S-nitrosylation of cysteine 360 in the active site of the enzyme, J BIOL CHEM, 276(37), 2001, pp. 34458-34464
Citation: Dj. Feith et al., Targeted antizyme expression in the skin of transgenic mice reduces tumor promoter induction of ornithine decarboxylase and decreases sensitivity to chemical carcinogenesis, CANCER RES, 61(16), 2001, pp. 6073-6081
Authors:
Pourquier, P
Waltman, JL
Urasaki, Y
Loktionova, NA
Pegg, AE
Nitiss, JL
Pommier, Y
Citation: P. Pourquier et al., Topoisomerase I-mediated cytotoxicity of N-methyl-N '-nitro-N-nitrosoguanidine: Trapping of topoisomerase I by the O-6-methylguanine, CANCER RES, 61(1), 2001, pp. 53-58
Authors:
Tolbert, WD
Ekstrom, JL
Mathews, II
Secrist, JA
Kapoor, P
Pegg, AE
Ealick, SE
Citation: Wd. Tolbert et al., The structural basis for substrate specificity and inhibition of human S-adenosylmethionine decarboxylase (vol 40, pg 9484, 2001), BIOCHEM, 40(43), 2001, pp. 13124-13124
Authors:
Tolbert, WD
Ekstrom, JL
Mathews, II
Secrist, JA
Kapoor, P
Pegg, AE
Ealick, SE
Citation: Wd. Tolbert et al., The structural basis for substrate specificity and inhibition of human S-adenosylmethionine decarboxylase, BIOCHEM, 40(32), 2001, pp. 9484-9494
Citation: Jl. Ekstrom et al., Structure of a human S-adenosylmethionine decarboxylase self-processing ester intermediate and mechanism of putrescine stimulation of processing as revealed by the H243A mutant, BIOCHEM, 40(32), 2001, pp. 9495-9504
Citation: H. Liu et al., The role of human O-6-alkylguanine-DNA alkyltransferase in promoting 1,2-dibromoethane-induced genotoxicity in Escherichia coli, MUT RES-F M, 452(1), 2000, pp. 1-10
Authors:
Patel, VJ
Elion, GB
Houghton, PJ
Keir, S
Pegg, AE
Johnson, SP
Dolan, ME
Bigner, DD
Friedman, HS
Citation: Vj. Patel et al., Schedule-dependent activity of temozolomide plus CPT-11 against a human central nervous system tumor-derived xenograft, CLIN CANC R, 6(10), 2000, pp. 4154-4157
Authors:
Friedman, HS
Pluda, J
Quinn, JA
Ewesuedo, RB
Long, L
Friedman, AH
Cokgor, I
Colvin, OM
Haglund, MM
Ashley, DM
Rich, JN
Sampson, J
Pegg, AE
Moschel, RC
McLendon, RE
Provenzale, JM
Stewart, ES
Tourt-Uhlig, S
Garcia-Turner, AM
Herndon, JE
Bigner, DD
Dolan, ME
Citation: Hs. Friedman et al., Phase I trial of carmustine plus O-6-benzylguanine for patients with recurrent or progressive malignant glioma, J CL ONCOL, 18(20), 2000, pp. 3522-3528
Authors:
Keir, ST
Dolan, ME
Pegg, AE
Lawless, A
Moschel, RC
Bigner, DD
Friedman, HS
Citation: St. Keir et al., O-6-benzylguanine-mediated enhancement of nitrosourea activity in Mer(-) central nervous system tumor xenografts - implications for clinical trials, CANC CHEMOT, 45(6), 2000, pp. 437-440
Citation: Dm. Kokkinakis et al., Potentiation of BCNU antitumor efficacy by 9-substituted O-6-benzylguanines. Effect of metabolism, CANC CHEMOT, 45(1), 2000, pp. 69-77
Citation: Ca. Mackintosh et Ae. Pegg, Effect of spermine synthase deficiency on polyamine biosynthesis and content in mice and embryonic fibroblasts, and the sensitivity of fibroblasts to1,3-bis-(2-chloroethyl)-N-nitrosourea, BIOCHEM J, 351, 2000, pp. 439-447
Authors:
Mackintosh, CA
Feith, DJ
Shantz, LM
Pegg, AE
Citation: Ca. Mackintosh et al., Overexpression of antizyme in the hearts of transgenic mice prevents the isoprenaline-induced increase in cardiac ornithine decarboxylase activity and polyamines, but does not prevent cardiac hypertrophy, BIOCHEM J, 350, 2000, pp. 645-653
Citation: M. Xu-welliver et Ae. Pegg, Point mutations at multiple sites including highly conserved amino acids maintain activity, but render O-6-alkylguanine-DNA alkyltransferase insensitive to O-6-benzylguanine, BIOCHEM J, 347, 2000, pp. 519-526
Authors:
Xu-Welliver, M
Kanugula, S
Loktionova, NA
Crone, TM
Pegg, AE
Citation: M. Xu-welliver et al., Conserved residue lysine(165) is essential for the ability of O-6-alkylguanine-DNA alkyltransferase to react with O-6-benzylguanine, BIOCHEM J, 347, 2000, pp. 527-534
Authors:
Daniels, DS
Mol, CD
Arvai, AS
Kanugula, S
Pegg, AE
Tainer, JA
Citation: Ds. Daniels et al., Active and alkylated human AGT structures: a novel zinc site, inhibitor and extrahelical base binding, EMBO J, 19(7), 2000, pp. 1719-1730